Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]
Yin P, Li H, Ke C, et al. Int J Nanomedicine. 2020;15:1499—1515. The authors have advised Figure 5A on page 1511 is incorrect. Due to an error at the time of figure assembly day 21 Au@PP/poly(I:C)+TMZ and day 28 Au@PP/poly(I:C)+TMZ in the HE 200× row were duplic...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-11-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/corrigendum-intranasal-delivery-of-immunotherapeutic-nanoformulations--peer-reviewed-article-IJN |
id |
doaj-1e396a273c2e474395861374f3f7c4e7 |
---|---|
record_format |
Article |
spelling |
doaj-1e396a273c2e474395861374f3f7c4e72020-12-02T18:37:41ZengDove Medical PressInternational Journal of Nanomedicine1178-20132020-11-01Volume 158873887459169Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]Yin PLi HKe CCao GXin XHu JCai XLi LLiu XDu BYin P, Li H, Ke C, et al. Int J Nanomedicine. 2020;15:1499—1515. The authors have advised Figure 5A on page 1511 is incorrect. Due to an error at the time of figure assembly day 21 Au@PP/poly(I:C)+TMZ and day 28 Au@PP/poly(I:C)+TMZ in the HE 200× row were duplicated. The correct Figure 5 is shown below. The authors apologize for this error and advise it does not affect the results of the paper. Read the original article https://www.dovepress.com/corrigendum-intranasal-delivery-of-immunotherapeutic-nanoformulations--peer-reviewed-article-IJNaunpspoly (i:c)intranasal administrationimmunogenic cell deathin situ immune response activation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yin P Li H Ke C Cao G Xin X Hu J Cai X Li L Liu X Du B |
spellingShingle |
Yin P Li H Ke C Cao G Xin X Hu J Cai X Li L Liu X Du B Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum] International Journal of Nanomedicine aunps poly (i:c) intranasal administration immunogenic cell death in situ immune response activation |
author_facet |
Yin P Li H Ke C Cao G Xin X Hu J Cai X Li L Liu X Du B |
author_sort |
Yin P |
title |
Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum] |
title_short |
Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum] |
title_full |
Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum] |
title_fullStr |
Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum] |
title_full_unstemmed |
Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum] |
title_sort |
intranasal delivery of immunotherapeutic nanoformulations for treatment of glioma through in situ activation of immune response [corrigendum] |
publisher |
Dove Medical Press |
series |
International Journal of Nanomedicine |
issn |
1178-2013 |
publishDate |
2020-11-01 |
description |
Yin P, Li H, Ke C, et al. Int J Nanomedicine. 2020;15:1499—1515.
The authors have advised Figure 5A on page 1511 is incorrect. Due to an error at the time of figure assembly day 21 Au@PP/poly(I:C)+TMZ and day 28 Au@PP/poly(I:C)+TMZ in the HE 200× row were duplicated. The correct Figure 5 is shown below.
The authors apologize for this error and advise it does not affect the results of the paper.
Read the original article
|
topic |
aunps poly (i:c) intranasal administration immunogenic cell death in situ immune response activation |
url |
https://www.dovepress.com/corrigendum-intranasal-delivery-of-immunotherapeutic-nanoformulations--peer-reviewed-article-IJN |
work_keys_str_mv |
AT yinp intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum AT lih intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum AT kec intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum AT caog intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum AT xinx intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum AT huj intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum AT caix intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum AT lil intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum AT liux intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum AT dub intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum |
_version_ |
1724403429128798208 |